Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
出版年份 2013 全文链接
标题
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
作者
关键词
Fibroblast growth factor 21, Coronary artery disease, Non-alcoholic fatty liver disease, Metabolic syndrome
出版物
Cardiovascular Diabetology
Volume 12, Issue 1, Pages 124
出版商
Springer Nature
发表日期
2013-08-28
DOI
10.1186/1475-2840-12-124
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
- (2013) Huating Li et al. Frontiers of Medicine
- Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
- (2012) Ryuichi Kawamoto et al. Cardiovascular Diabetology
- Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
- (2012) Marina Shargorodsky et al. Cardiovascular Diabetology
- Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques
- (2012) So-Yeon An et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
- (2012) Pedro Iglesias et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Relationship of Serum Fibroblast Growth Factor 21 with Abnormal Glucose Metabolism and Insulin Resistance: The Baltimore Longitudinal Study of Aging
- (2012) Richard D. Semba et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
- (2012) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
- (2012) Huating Li et al. JOURNAL OF HEPATOLOGY
- Serum FGF-21 Levels in Type 2 Diabetic Patients
- (2011) Xingbo Cheng et al. ENDOCRINE RESEARCH
- Serum fibroblast growth factor 21 levels in polycystic ovary syndrome
- (2010) Suheyla Gorar et al. GYNECOLOGICAL ENDOCRINOLOGY
- Liver Fat But Not Other Adiposity Measures Influence Circulating FGF21 Levels in Healthy Young Adult Twins
- (2010) Henna Tyynismaa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects
- (2009) Huating Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia
- (2009) Sebastian Stein et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search